What's new

Human medicines European public assessment report (EPAR): Sugammadex Mylan, sugammadex, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Sugammadex Mylan, sugammadex, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised

Mar 12, 2025 - 16:47
 0
Human medicines European public assessment report (EPAR): Sugammadex Mylan, sugammadex, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Sugammadex Mylan, sugammadex, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

J&J’s Monarch bronchoscopy robot cleared by FDA to connect to live CT scans

Next Article

Human medicines European public assessment report (EPAR): Yselty, linzagolix cho...

Related Posts

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Orphan designation: Adeno-associated viral vector serotype 9 containing the human iduronate-2-sulfatase gene Treatment of mucopolysaccharidosis type II (Hunter's syndrome), 10/08/2015 Withdrawn

Orphan designation: Adeno-associated viral vector serot...

Feb 20, 2025  0

Regulatory Procedure Management (RPM) for the Product L...

Mar 3, 2025  0